R M Anthony
Overview
Explore the profile of R M Anthony including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anthony R, Tagliani E, Nikolayevskyy V, de Zwaan R, Mulder A, Kamst M, et al.
Microbiol Spectr
. 2022 Dec;
11(1):e0224422.
PMID: 36475728
Here, we report the development and key features of the first external quality assessment (EQA) scheme for Mycobacterium tuberculosis whole-genome sequencing (WGS). The results of four rounds (2017 to 2020)...
2.
Zhang Y, Wang F, van Soolingen D, Anthony R
Public Health Action
. 2022 Jun;
12(2):64-67.
PMID: 35734008
Objective: To compare the clinical characteristics and laboratory results of pulmonary TB (PTB) patients with and without diabetes mellitus (DM) and the relationship between haemoglobin A1C (HbA1c) concentration and mycobacterial...
3.
Anthony R, den Hertog A, van Soolingen D
J Antimicrob Chemother
. 2018 Mar;
73(7):1750-1754.
PMID: 29528413
A low pH was assumed to be required for the activity of pyrazinoic acid (the active form of pyrazinamide) against Mycobacterium tuberculosis, but recently activity has been demonstrated at neutral...
4.
Anthony R, Cynamon M, Hoffner S, Werngren J, den Hertog A, van Soolingen D
Antimicrob Agents Chemother
. 2017 May;
61(6).
PMID: 28539498
No abstract available.
5.
Vant Hoog A, Bergval I, Tukvadze N, Sengstake S, Aspindzelashvili R, Anthony R, et al.
BMC Infect Dis
. 2015 Oct;
15:473.
PMID: 26503434
Background: Molecular resistance detection (MRD) of resistance to second-line anti-tuberculous drugs provides faster results than phenotypic tests, may shorten treatment and allow earlier separation among patients with and without second-line...
6.
No added value of performing Ziehl-Neelsen on auramine-positive samples for tuberculosis diagnostics
den Hertog A, Daher S, Straetemans M, Scholing M, Anthony R
Int J Tuberc Lung Dis
. 2013 Jul;
17(8):1094-9.
PMID: 23827035
Setting: Regional Laboratory for Tuberculosis, Amsterdam, The Netherlands. Background: There is a push to switch from Ziehl-Neelsen (ZN) to auramine microscopy. Despite World Health Organization guidelines that one staining method...
7.
Streicher E, Bergval I, Dheda K, Bottger E, Gey van Pittius N, Bosman M, et al.
Antimicrob Agents Chemother
. 2012 Feb;
56(5):2420-7.
PMID: 22330913
The global emergence of multidrug-resistant tuberculosis has highlighted the need for the development of rapid tests to identify resistance to second-line antituberculosis drugs. Resistance to fluoroquinolones and aminoglycosides develops through...
8.
Crespo E, de Ronde H, Kuijper S, Pol A, Kolk A, Cristescu S, et al.
Rapid Commun Mass Spectrom
. 2012 Feb;
26(6):679-85.
PMID: 22328222
Rationale: Several mycobacterial species can produce serious infections in humans, and the treatment required depends on the infecting species. Fast identification, ideally with minimal manipulation of the infecting species, is...
9.
Crespo E, Cristescu S, de Ronde H, Kuijper S, Kolk A, Anthony R, et al.
J Microbiol Methods
. 2011 Feb;
86(1):8-15.
PMID: 21277343
The metabolic activity of plants, animals or microbes can be monitored by gas headspace analysis. This can be achieved using Proton Transfer Reaction Mass Spectrometry (PTR-MS), a highly sensitive detection...
10.
Anthony R, Cobelens F, Gebhard A, Klatser P, Lumb R, Rusch-Gerdes S, et al.
Int J Tuberc Lung Dis
. 2009 Sep;
13(9):1051-3.
PMID: 19723391
Attempts to improve the diagnosis of tuberculosis (TB) in high-burden countries has resulted in significant funding and initiatives to change the method of diagnosis of TB from light microscopy supplemented...